FEI GAO

Dr. FEI GAO


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Phytotherapy Research
Verified
Journal Article
Closed access
LDLingling Dong
Lingling Dong
HDHongling Du
Hongling Du
MZMinyue Zhang
Minyue Zhang
HXHaiting Xu
Haiting Xu
XPXiulan Pu
Xiulan Pu
FGFEI GAO
FEI GAO

1 September 2021 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
MZMenghang Zu
Menghang Zu
YMYa Ma
Ya Ma
BCBrandon Cannup
Brandon Cannup
DXDengchao Xie
Dengchao Xie
Yunjin JungYunjin Jung
Yunjin Jung
BXBo Xiao
Bo Xiao

1 July 2021 in Carbohydrate Polymers
Verified
Journal Article
Closed access
RLRuifeng Luo
Ruifeng Luo
MLMeisi Lin
Meisi Lin
CFChaomei Fu
Chaomei Fu
JZJinming Zhang
Jinming Zhang
QCQiyan Chen
Qiyan Chen
FGFEI GAO
FEI GAO

1 November 2020 in Food Chemistry
Verified
Journal Article
Closed access
RLRuifeng Luo
Ruifeng Luo
MLMeisi Lin
Meisi Lin
CZChen Zhang
Chen Zhang
JSJinfeng Shi
Jinfeng Shi
SZSiyuan Zhang
Siyuan Zhang
FGFEI GAO
FEI GAO

1 November 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
KGKumar Ganesan
Kumar Ganesan
YWYan Wang
Yan Wang
FGFEI GAO
FEI GAO
QLQingqing Liu
Qingqing Liu
CZChen Zhang
Chen Zhang
Jiianping ChenJiianping Chen
Jiianping Chen
Breast cancer (BC) is the second most common cancer in women globally after lung cancer. Presently, the most important approach for BC treatment consists of surgery, followed by radiotherapy and chemotherapy. The latter therapeutic methods are often unsuccessful in the treatment of BC because of their various side effects and the damage incurred to healthy tissues and organs. Currently, numerous nanoparticles (NPs) have been identified and synthesized to selectively target BC cells without causing any impairments to the adjacent normal tissues or organs. Based on an exploratory study, this comprehensive review aims to provide information on engineered NPs and their payloads as promising tools in the treatment of BC. Therapeutic drugs or natural bioactive compounds generally incorporate engineered NPs of ideal sizes and shapes to enhance their solubility, circulatory half-life, and biodistribution, while reducing their side effects and immunogenicity. Furthermore, ligands such as peptides, antibodies, and nucleic acids on the surface of NPs precisely target BC cells. Studies on the synthesis of engineered NPs and their impact on BC were obtained from PubMed, Science Direct, and Google Scholar. This review provides insights on the importance of engineered NPs and their methodology for validation as a next-generation platform with preventive and therapeutic effects against BC.

7 September 2023 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
XHXiaoqin Han
Xiaoqin Han
RLRuifeng Luo
Ruifeng Luo
SQShanshan Qi
Shanshan Qi
YWYanli Wang
Yanli Wang
LDLinxin Dai
Linxin Dai
FGFEI GAO
FEI GAO
Ulcerative colitis (UC) faces some barriers in oral therapy, such as how to safely deliver drugs to the colon and accumulate in the colon lesions. Hence, we report an advanced yeast particles system loaded with supramolecular nanoparticles with ROS scavenger (curcumin) to treat UC by reducing oxidative stress state and inflammatory response and accelerating the reprogramming of macrophages. In this study, the dual-sensitive materials are bonded on β-cyclodextrin (β-CD), the D-mannose (Man) is modified to adamantane (ADA), and then loaded with curcumin (CUR), to form a functional supramolecular nano-delivery system (Man-CUR NPs) through the host-guest interaction. To improve gastrointestinal stability and colonic accumulation of Man-CUR NPs, yeast cell wall microparticles (YPs) encapsulated Man-CUR NPs to form Man-CUR NYPs via electrostatic adsorption and vacuum extrusion technologies. As expected, the YPs showed the strong stability in complex gastrointestinal environment. In addition, the Man modified supramolecular nanoparticles demonstrated excellent targeting ability to macrophages in the in vitro cellular uptake study and the pH/ROS sensitive effect of Man-CUR NPs was confirmed by the pH/ROS-dual stimulation evaluation. They also enhanced lipopolysaccharide (LPS)-induced inflammatory model in macrophages through downregulation of pro-inflammatory factors, upregulation of anti-inflammatory factors, M2 macrophage polarization, and scavenging the excess ROS. Notably, in DSS-induced mice colitis model, Man-CUR NYPs can reduce the inflammatory responses by modulating TLR4/NF-κB signaling pathways, alleviate oxidative stress by Nrf2/HO-1 signaling pathway, promote macrophages reprogramming and improve the favorable recovery of the damaged colonic tissue. Taken together, this study not only provides strategy for “supramolecular curcumin nanoparticles with pH/ROS sensitive and multistage therapeutic effects” in “advanced yeast particles”, but also provided strong theoretical support multi-effect therapy for UC.